Skip to main content
BrainCited

Ginkgo biloba के लिए Age-Related Cognitive Decline

C

The most studied herbal cognitive supplement. The large GEM trial (3,069 participants) found no evidence for dementia prevention in healthy elderly. However, EGb 761 standardized extract shows modest benefits in existing cognitive impairment.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dginkgo\u002Dbiloba\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

निष्कर्ष

The most studied herbal cognitive supplement. The large GEM trial (3,069 participants) found no evidence for dementia prevention in healthy elderly. However, EGb 761 standardized extract shows modest benefits in existing cognitive impairment.

Key Study Findings

Review
EGb761 Trials for Mild-to-Moderate Dementia-What Have We Learned in the Past 18 years?
Dose: None बनाम: placebo Outcome: cognitive assessment scores (MMSE, SKT, NPI) प्रभाव: None None

जनसंख्या: patients with mild-to-moderate Alzheimer disease or vascular dementia

Review
Vascular cognitive impairment and dementia: Prevention, treatments, mechanisms and management options for the future.
Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: patients with vascular cognitive impairment and dementia

Review
The Use of Natural Products for Preventing Cognitive Decline/Providing Neuroprotection.
Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: Review of natural products for neuroprotection

Review
Can supplementation with antioxidants improve cognitive functions in patients with multiple sclerosis? A literature review.
Dose: None बनाम: None Outcome: Cognitive function in multiple sclerosis प्रभाव: None None

जनसंख्या: Multiple sclerosis patients (review)

Review
Nutritional strategies against dementia in rural populations.
Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: Rural populations with dementia risk

Cohort Study n=64 52 weeks Open-label
Efficacy of Ginkgo biloba extract in amyloid PET-positive patients with mild cognitive impairment.
Dose: 240 mg/day बनाम: Standard cognitive enhancers Outcome: Cognitive responder rate and AD conversion प्रभाव: 100% vs 59.1% responders; 0% vs 13.6% AD conversio <0.001 (responders); 0.037 (AD

जनसंख्या: Amyloid PET-positive MCI patients

Key Statistics

40

अध्ययन

8000

प्रतिभागी

Mixed

C

ग्रेड

Referenced Papers

Handbook of experimental … 2025 1 उद्धरण
Biomolecules 2021 161 उद्धरण
Pharmaceuticals (Basel, Switzerland) 2021 33 उद्धरण
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2020 4 उद्धरण
Acta bio-medica : … 2018 103 उद्धरण
Pharmacological research 2018 67 उद्धरण
Frontiers in nutrition 2018 18 उद्धरण
Journal of Alzheimer's … 2017 17 उद्धरण
Age (Dordrecht, Netherlands) 2014
Clinical pharmacokinetics 2013 220 उद्धरण
American family physician 2011
JAMA 2010 3 उद्धरण
The Practitioner 2010
The Cochrane database … 2009 299 उद्धरण
Epidemiologic reviews 2008 172 उद्धरण
Neuro endocrinology letters 2008
The Cochrane database … 2007 375 उद्धरण
The Proceedings of … 2002 191 उद्धरण
The Cochrane database … 2002
Alternative medicine review … 1999 112 उद्धरण
Current opinion in … 1998 30 उद्धरण
British journal of … 1993 8 उद्धरण

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

general:
120-240 mg/day standardized to 24% flavone glycosides and 6% terpene lactones

अधिकतम सीमा: 600 mg/day (doses above show no additional benefit)

अनुसंधान में अध्ययन की गई खुराकें

खुराक अवधि प्रभाव N
None -- Mixed --
None -- Mixed --
None -- Mixed --
None -- Mixed --
None -- Mixed --
240 mg/day 52 weeks Positive 64
None -- Positive --
None -- Neutral --

सेवन का सर्वोत्तम समय: With meals; may require 4-6 weeks for full effects

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

  • Headache
  • Gastrointestinal upset
  • Dizziness
  • Allergic skin reactions (rare)
  • Increased bleeding risk

ज्ञात अंतःक्रियाएँ

  • Anticoagulants and antiplatelet drugs (increased bleeding risk)
  • Anticonvulsants (may reduce seizure threshold)
  • SSRIs (serotonin syndrome risk, rare)
  • CYP3A4 substrates (may affect drug metabolism)

सहनीय अधिकतम सेवन: 600 mg/day (doses above show no additional benefit)

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does Ginkgo biloba help with Age-Related Cognitive Decline?
Based on 40 studies with 8,000 participants, there is limited but promising evidence that Ginkgo biloba may support Age-Related Cognitive Decline management. Our evidence grade is C (Some Evidence).
How much Ginkgo biloba should I take for Age-Related Cognitive Decline?
Studies have used various dosages. A commonly studied range is 120-240 mg/day standardized to 24% flavone glycosides and 6% terpene lactones. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Ginkgo biloba?
Reported side effects may include Headache, Gastrointestinal upset, Dizziness, Allergic skin reactions (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Ginkgo biloba and Age-Related Cognitive Decline?
We rate the evidence as Grade C (Some Evidence). This rating is based on 40 peer-reviewed studies with 8,000 total participants. The overall direction of effect is mixed.

Related Evidence

इसके लिए अन्य सामग्री Age-Related Cognitive Decline

Ginkgo biloba अन्य स्वास्थ्य स्थितियों के लिए

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।